Gut microbiome as a response marker for pancreatic enzyme replacement therapy in a porcine model of exocrine pancreas insufficiency

BACKGROUND: Exocrine pancreatic insufficiency (EPI) is characterized by the loss of active pancreatic enzymes and a resulting severely reduced food digestion. EPI therapy requires orally applied pancreatic enzyme replacement. The gut microbiome is a known mediator of intestinal diseases and may infl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ritz, Sabrina, Hahn, Daniela, Wami, Haleluya T., Tegelkamp, Karin, Dobrindt, Ulrich, Schnekenburger, Juergen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713139/
https://www.ncbi.nlm.nih.gov/pubmed/33272255
http://dx.doi.org/10.1186/s12934-020-01482-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713139/
https://www.ncbi.nlm.nih.gov/pubmed/33272255
http://dx.doi.org/10.1186/s12934-020-01482-2

Ejemplares similares